These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28427786)

  • 1. Reply to Philipp Dahm, Vikram Narayan, and Jae Hung Jung's Letter to the Editor re: Richard J. Sylvester, Steven E. Canfield, Thomas B.L. Lam, et al. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. Eur Urol 2017;71:811-9.
    Lam TBL; Sylvester RJ; Canfield SE; Marconi L; MacLennan S; Yuan Y; Omar MI; N'Dow J
    Eur Urol; 2017 Oct; 72(4):e93-e94. PubMed ID: 28427786
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Richard J. Sylvester, Steven E. Canfield, Thomas B.L. Lam, et al. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. Eur Urol 2017;71:811-9.
    Dahm P; Narayan V; Jung JH
    Eur Urol; 2017 Oct; 72(4):e91-e92. PubMed ID: 28433379
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Stephen B. Williams, Donald L. Lamm, Ashish M. Kamat's Letter to the Editor re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
    Sylvester R
    Eur Urol; 2015 Dec; 68(6):e128. PubMed ID: 26320375
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Behnam Shakiba's letter to the editor re: Philipp Dahm, James N'Dow, Lars Holmberg, Freddie Hamdy. The future of randomised controlled trials in urology. Eur Urol 2014;66:1-3.
    Dahm P; N'Dow J; Holmberg L; Hamdy F
    Eur Urol; 2014 Jul; 66(1):e8. PubMed ID: 24690208
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Per-Uno Malmström and Bruce J. Trock's Letter to the Editor re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
    Sylvester R
    Eur Urol; 2016 Jan; 69(1):e12-3. PubMed ID: 26215601
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
    Eur Urol; 2016 Nov; 70(5):e141-e142. PubMed ID: 27157996
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Jae Hung Jung, Julia L. Han, and Philipp Dahm's Letter to the Editor re: Vasileios I. Sakalis, Markos Karavitakis, Dina Bedretdinova, et al. Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms. Eur Urol 2017;72:757-69.
    Sakalis VI; Gravas S; Drake MJ
    Eur Urol; 2018 Mar; 73(3):e60-e62. PubMed ID: 29233662
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Lorenzo Marconi, Steven MacLennan, Thomas B.L. Lam, et al's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
    Derweesh IH; Mir MC; Autorino R
    Eur Urol; 2017 Sep; 72(3):e61-e62. PubMed ID: 28642021
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.
    Lamm D; Böhle A; Palou J; Persad R; Brausi M; Colombel M; Akaza H; Buckley R
    Eur Urol; 2010 Feb; 57(2):e7-9; author reply e10-1. PubMed ID: 19914768
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.
    Aldemir M; Canda AE; Balbay MD
    Eur Urol; 2010 Aug; 58(2):e23; author reply e24-5. PubMed ID: 20542629
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
    Malmström PU; Trock BJ
    Eur Urol; 2016 Jan; 69(1):e10-1. PubMed ID: 26215603
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Carsten Stephan, Henning Cammann, and Klaus Jung's Letter to the Editor re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039.
    Tomlins SA; Groskopf J; Chinnaiyan AM
    Eur Urol; 2015 Nov; 68(5):e108. PubMed ID: 26242717
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to E. Jason Abel Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
    Eur Urol; 2016 Jun; 69(6):e119-20. PubMed ID: 26776936
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
    Williams SB; Lamm DL; Kamat AM
    Eur Urol; 2015 Dec; 68(6):e127. PubMed ID: 26318707
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Philipp Dahm, James N'Dow, Lars Holmberg, Freddie Hamdy. The future of randomised controlled trials in urology. Eur Urol 2014;66:1-3.
    Shakiba B
    Eur Urol; 2014 Jul; 66(1):e7. PubMed ID: 24657233
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Jae Heon Kim, Bora Lee, and Benjamin I. Chung's Letter to the Editor re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50.
    Mandel P; Tilki D
    Eur Urol; 2017 Dec; 72(6):e176. PubMed ID: 28709729
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Emily Vertosick and Andrew Vickers' letter to the editor re: Alberto Briganti, Thomas Wiegel, Steven Joniau, et al. early salvage radiation therapy does not compromise cancer control in patients with pT3N0 Prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 2012;62:472-87.
    Briganti A
    Eur Urol; 2013 Apr; 63(4):e51-2. PubMed ID: 23305881
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur Urol 2016;69:60-9.
    Sylvester R; Gontero P; Oddens J
    Eur Urol; 2016 Jun; 69(6):e123-4. PubMed ID: 26874805
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Christopher R. Chapple, Vik Khullar, Zahava Gabriel, et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008;54:543-62.
    Staskin DR; Oefelein MG
    Eur Urol; 2009 Mar; 55(3):e49-50; author reply e51. PubMed ID: 18829154
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Jae Heon Kim's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 2016;70:788-96.
    Gacci M; Vignozzi L; Corona G; Serni S; Maggi M
    Eur Urol; 2017 Apr; 71(4):e119-e120. PubMed ID: 27816298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.